Title:
Digital therapeutics for older adults: using mobile technology to deliver therapies anytime and anywhere
Agreement Value:
$434,203.00
Agreement Date:
Sep 1, 2022 - Feb 28, 2026
Description:
Non-pharmacological interventions centered around lifestyle modifications constitute promising approaches to delay the onset or progression of neurodegenerative diseases impacting cognition. An important challenge for the implementation of such interventions is the ability to deliver them in an accessible PAGE 4 and ecological context. To address these challenges, mobile technologies have been increasingly used over the past decade to provide health-related assessments or interventions for older adults in their own living environment. The extent to which mobile assessments and interventions can be integrated to improve health outcomes deserves further investigation. In this project, we will investigate the feasibility and benefits of developing and using a digital phenotyping approach based on remote assessments of sleep and cognition in older adults in the community. We will then explore whether such digital phenotyping may improve the outcomes of a web-based intervention that was developed to promote better sleep and brain health in older adults. This phenotyping approach will allow to collect information on lifestyle factors such as sleep, passively using sensors and actively via short surveys and tasks. Using it, the CRIUGM will run several user-based studies and validate its feasibility with older adults. The integration of measures from the phenotyping approach into the web-based intervention platform is to be used to improve an online sleep-related intervention by tailoring it to the individual’s needs. In addition, it is expected that this integration between remote assessments and intervention will also improve personalized feedback to the user during the intervention, and therefore improve acceptability, engagement, and adherence of older adults to the intervention.
Organization:
National Research Council Canada
Expected Results:
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Location:
Montreal, Quebec, CA H2L 4M1
Reference Number:
172-2022-2023-Q2-996558
Report Type:
Grants and Contributions
Recipient Business Number:
141690743
Additional Information:
This agreement has been amended 1 time(s) the total amended value is $434,203.The end date of this agreement has been modified by 180 days.
Amendment Date
Jun 6, 2024
Recipient's Legal Name:
Centre intégré universitaire de santé et de services sociaux du Centre-Sud-de-l'Île-de-Montréal
Federal Riding Name:
Laurier--Sainte-Marie
Federal Riding Number:
24037
Program:
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Purpose:
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
NAICS Code:
541710 - R&D in the physical, engineering and life sciences